* US FDA approved continued access to ReCell, allowing US
burns surgeons participating in co’s regulatory trial to treat
new patients using co’s cell harvesting device
The post BRIEF-Avita Medical says FDA approves continued access to ReCell in US burns trial appeared first on NASDAQ.